Medicare Enrolled
Dr. Ramana Dutt, MD
Medical Oncology · Brooksville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dutt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dutt? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dutt
Dr. Ramana Dutt is a medical oncology in Brooksville, FL, with 20 years in practice. Based on federal Medicare data, Dr. Dutt performed 58,495 Medicare services across 1,621 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dutt received a total of $14,188 from 90 pharmaceutical and/or device companies across 763 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dutt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 32% volume in FL$ $14,188 industry payments
Medicare Practice Summary
Medicare Utilization ↗58,495
Medicare services
Top 32% in FL for medical oncology
1,621
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,925 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 26,010 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 14,310 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 4,810 | $1 | $5 |
| Complete blood count (CBC) with differential | 1,406 | $8 | $29 |
| Blood draw (venipuncture) | 1,219 | $8 | $9 |
| Dexamethasone injection (steroid) | 1,118 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,090 | $1 | $28 |
| Drug injection, under skin or into muscle | 740 | $10 | $69 |
| Office visit, established patient (30-39 min) | 581 | $96 | $339 |
| Office visit, established patient (20-29 min) | 303 | $63 | $239 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 268 | $1 | $6 |
| Injection of additional new drug or substance into vein | 203 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 157 | $97 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 153 | $21 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 127 | $45 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 118 | $15 | $56 |
| Administration of chemotherapy into vein, each additional hour | 92 | $21 | $79 |
| Injection, diphenhydramine hcl, up to 50 mg | 83 | $1 | $3 |
| Infusion into a vein for hydration, each additional hour | 82 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 65 | $2 | $7 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 63 | $17 | $59 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 62 | $3 | $11 |
| Administration of additional new drug or substance into vein, 1 hour or less | 56 | $48 | $178 |
| Infusion into a vein for hydration, 31-60 minutes | 54 | $24 | $156 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 27 | $15 | $56 |
| New patient office visit (45-59 min) | 24 | $106 | $453 |
| Red blood count, automated test | 21 | $4 | $10 |
| Injection of drug or substance into vein | 19 | $28 | $156 |
| Initial hospital admission, high complexity | 14 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
45.5% high complexity
48.2% medium
6.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,188
Total received (2018-2024)
Avg $2,027/year across 7 years
Top 37% in FL for medical oncology
90
Companies
763
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,015 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$173 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,884
2023$2,624
2022$1,732
2021$1,207
2020$1,119
2019$2,386
2018$2,236
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$1,171
Novartis Pharmaceuticals Corporation
$895
AstraZeneca Pharmaceuticals LP
$737
Celgene Corporation
$681
Genentech USA, Inc.
$557
PFIZER INC.
$548
Janssen Biotech, Inc.
$511
Merck Sharp & Dohme LLC
$510
Lilly USA, LLC
$447
GENZYME CORPORATION
$439
Amgen Inc.
$431
Merck Sharp & Dohme Corporation
$397
Incyte Corporation
$384
Bayer HealthCare Pharmaceuticals Inc.
$347
Astellas Pharma US Inc
$333
Eisai Inc.
$310
Takeda Pharmaceuticals U.S.A., Inc.
$302
Gilead Sciences, Inc.
$292
Seagen Inc.
$288
Daiichi Sankyo Inc.
$244
GlaxoSmithKline, LLC.
$239
EMD Serono, Inc.
$168
EISAI INC.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
G1 Therapeutics, Inc.
$160
CSL Behring
$156
Janssen Pharmaceuticals, Inc
$151
Bayer Healthcare Pharmaceuticals Inc.
$145
Regeneron Healthcare Solutions, Inc.
$131
Alexion Pharmaceuticals, Inc.
$123
TESARO, Inc.
$122
Genmab U.S., Inc.
$122
ARRAY BIOPHARMA INC
$98
AMAG Pharmaceuticals, Inc.
$96
PUMA BIOTECHNOLOGY, INC.
$91
INSYS Therapeutics Inc
$87
Seattle Genetics, Inc.
$84
Janssen Products, LP
$77
Pharmacyclics LLC, An AbbVie Company
$77
AbbVie Inc.
$70
Agios Pharmaceuticals, Inc.
$66
Kyowa Kirin, Inc.
$64
Rigel Pharmaceuticals, Inc.
$63
Deciphera Pharmaceuticals Inc.
$61
JAZZ PHARMACEUTICALS INC.
$60
Array BioPharma Inc.
$59
BeiGene USA, Inc.
$58
Pharmacosmos Therapeutics Inc.
$57
Puma Biotechnology, Inc.
$57
Sun Pharmaceutical Industries Inc.
$57
Tempus AI, Inc
$56
SOBI, INC
$52
Dova Pharmaceuticals
$52
Mirati Therapeutics, Inc.
$49
Stemline Therapeutics Inc.
$47
SERVIER PHARMACEUTICALS LLC
$46
Exelixis Inc.
$46
Kite Pharma, Inc.
$45
MEDIVATION FIELD SOLUTIONS LLC
$44
Aveo Pharmaceuticals, Inc.
$39
AVEO Pharmaceuticals, Inc.
$39
Partner Therapeutics, Inc.
$38
Foundation Medicine, Inc.
$38
Karyopharm Therapeutics Inc.
$38
Aurobindo Pharma USA, Inc.
$37
Global Blood Therapeutics, Inc.
$36
CTI BioPharma Corp.
$36
Teva Pharmaceuticals USA, Inc.
$36
Myovant Sciences Inc.
$35
Ipsen Biopharmaceuticals, Inc
$35
Helsinn Therapeutics (U.S.), Inc.
$32
Taiho Oncology, Inc.
$28
Fennec Pharmaceuticals, Inc.
$24
Heron Therapeutics, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$23
PharmaEssentia USA Corporation
$23
AbbVie, Inc.
$21
ABBVIE INC.
$20
ADC Therapeutics America, Inc.
$20
Sumitomo Pharma America, Inc.
$20
TerSera Therapeutics LLC
$19
Verastem, Inc.
$19
Alnylam Pharmaceuticals Inc.
$18
Myriad Genetic Laboratories, Inc.
$18
Novocure Inc.
$17
Alfasigma USA, Inc.
$14
Spectrum Pharmaceuticals Inc.
$14
Jazz Pharmaceuticals Inc.
$13
Advanced Accelerator Applications
$13
Veracyte, Inc.
$10
Top 3 companies account for 19.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Afstyla · Alecensa · Avastin · BAVENCIO · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMEND · ENHERTU · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · GIVLAARI · HEMGENIX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idelvion · Imbruvica · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUBSYS · SUTENT · SYLVANT · SYNDROS · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZIIHERA · ZYTIGA · Zevalin
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $24 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
9
Per 100K population
4.5
County median income
$63,193
Nearest hospital
HCA FLORIDA OAK HILL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dutt is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dutt experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dutt performed 26,010 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dutt receive payments from pharmaceutical companies?
Yes. Dr. Dutt received a total of $14,188 from 90 companies across 763 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dutt's costs compare to other medical oncologys in Brooksville?
Dr. Dutt's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dutt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Brooksville
Browse medical oncologys in Brooksville ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology